Last edition
News about "Manoj Joshi "
NIPER Mohali Partners with Novartis to Support Faculty Research
NIPER Mohali signs grant agreement with Novartis Healthcare to support faculty research through development pioneer grant, strengthen industry-academia synergy, and boost innovation and R&D capabilities.
Manoj Joshi | 16/04/2026 | By News Bureau
NIPER Raebareli Signs MoU with Roche Pharma India to Boost Pharma Education and Research
NIPER Raebareli partners with Roche Pharma India to launch regulatory training, industry lectures and AI-driven research initiatives, strengthening academia-industry collaboration in India’s pharmaceutical sector.
Manoj Joshi | 18/03/2026 | By News Bureau | 100
Boehringer Ingelheim India and NIPER Raebareli Sign MoU to Boost Pharma Education and Research
The MoU between NIPER Raebareli and Boehringer Ingelheim establishes a framework to strengthen academic and research collaboration in areas such as pharmaceutical technologies, novel drug delivery systems, joint research initiatives, academic exchange and capability-building programmes.
Manoj Joshi | 23/02/2026 | By News Bureau
PHARMEXCIL Engages Government Leaders to Strengthen Indian Pharmaceutical Export Growth
The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level discussions with key government stakeholders to align policy priorities, accelerate export momentum and reinforce India’s position in global pharmaceutical markets.
Manoj Joshi | 06/01/2026 | By News Bureau | 308
Manoj Joshi Assumes Charge as Secretary, Department of Pharmaceuticals
Senior Indian Administrative Service officer Manoj Joshi has taken charge as the new Secretary of the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers, following approval by the Appointments Committee of the Cabinet.
Manoj Joshi | 03/01/2026 | By Darshana | 233
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy